M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication
The findings of this study suggest that the antibody responses against M protein ectodomain in the population most likely exert a beneficial effect on preventing various SARS-CoV-2 infections.
Authors
- Xing‐Yi Ge (ORCID: https://orcid.org/0000-0003-3964-5140)
- Dejian Liu (ORCID: https://orcid.org/0000-0002-7643-6674)
- Wanyu Luo
- Shuofeng Yuan (ORCID: https://orcid.org/0000-0001-7996-1119)
- Kaiming Tang (ORCID: https://orcid.org/0000-0001-7310-6744)
- Yao-Qing Chen (ORCID: https://orcid.org/0000-0002-4659-1550)
- Hehe Cao
- Yunqi Hu
- Xinyu Yue
- Zi‐Wei Ye (ORCID: https://orcid.org/0000-0002-6446-4299)
- Cuiting Luo
- Yibo Tang
- Lei Deng (ORCID: https://orcid.org/0000-0003-2246-0801)
- Cuicui Liu (ORCID: https://orcid.org/0000-0002-5960-5851)
- Tianlong Liu (ORCID: https://orcid.org/0000-0003-3204-393X)
- Ran Wang (ORCID: https://orcid.org/0000-0002-3606-3527)
Institutions
- Sun Yat-sen University (CN)
- Hunan University (CN)
- National Medical Products Administration (CN)
- Beijing VDJBio (China) (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- Beijing Children’s Hospital (CN)
- China Agricultural University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.3389/fimmu.2024.1450114
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- DeepMind
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Hunan University
- National Key Research and Development Program of China